Methodology
The Brief Score, explained
Dose Brief is a newsroom, so we score providers the way we'd report them: on what actually happens to your price and your supply. Every GLP-1 provider on the board is scored out of 100 on the same six weighted factors — the identical rubric for providers we earn a commission from and providers we don't — and we say which is which on every card. A score is our editorial judgment, built from each provider's public disclosures and our tracking; it is never sold.
The six factors
1. Price Stability
22%The heaviest factor. Does the headline monthly price hold, or is it a teaser first-month rate that silently resets to full price? A flat, no-step-up line you can plan around scores highest; bait-and-switch tiers score lowest, no matter how low the intro number.
2. Supply Reliability
20%Whether the provider can actually keep filling your prescription — sourcing stability, pharmacy relationships, and exposure to the compounded-supply headlines and FDA shortage-list swings that strand patients mid-titration.
3. Transparency
18%How much the provider puts on the record: an explicit price, a named states-served list, clinician and supply-chain disclosure. Opaque 'contact us for pricing' models lose points here.
4. Access Breadth
15%How many states served, both molecules or one, and whether there are oral/sublingual and brand-name routes — the wider the honest access, the higher the score.
5. Clinical Oversight
13%Whether a licensed clinician — not just a web form — stands behind the prescription, with real titration guidance and side-effect support after the first vial ships.
6. Track Record
12%How long the provider has operated, how it has handled past pricing and supply changes, and whether its reputation holds up under scrutiny.
How we stay honest
- Same rubric for everyone. Partner and non-partner providers are scored on identical criteria. Affiliate status is disclosed inline and never adjusts a score.
- We report the losers too. Providers that fall short are scored low with the reasons stated. A ranking that flatters everyone isn't news.
- Facts are sourced, scores are judgment. Prices, states served, supply and verification reflect each provider's public disclosures at last check; the weighted score is ours.
- We re-check and date it. Telehealth pricing and supply change constantly — entries carry an “updated” dateline and get re-verified, and you should confirm current details on the provider's own site before deciding.
This page is editorial information, not medical advice. Compounded GLP-1 medications are not FDA-approved finished drug products. Talk to a licensed clinician before starting any weight-management medication. See our affiliate disclosure and medical disclaimer.